[BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
D000470:Alkaloids; D001161:Arteriosclerosis; D004304:Dosage Forms; D004358:Drug Therapy; D005342:Fibrinolysis; D005853:Geriatrics; D007267:Injections; D007275:Injections, Intravenous; D008082:Lipotropic Agents; D009525:Niacin; D009539:Nicotinic Acids; D015912:Thrombolytic Therapy; D014116:Toxicology
D000470:Alkaloids; D004304:Dosage Forms; D008082:Lipotropic Agents; D009539:Nicotinic Acids; D009525:Niacin
ALKALOIDS; ARTERIOSCLEROSIS; DOSAGE FORMS; DRUG THERAPY; FIBRINOLYSIS; GERIATRICS; INJECTIONS, INTRAVENOUS; LIPOTROPIC FACTORS; NICOTINIC ACID; TOXICOLOGIC REPORT
IL NICOTINATO DI BETAINA NELLA TERAPIA FIBRINOLITICA PROLUNGATA PER VIA ORALE.